Skip to main content
. 2010 Feb 15;207(2):291–297. doi: 10.1084/jem.20091983

Figure 3.

Figure 3.

Neutralizing auto-Abs against IL-17A in the plasma from a patient with APS-I. IL-6 production, after 48 h of stimulation with 50 ng/ml IL-17A, by control SV-40–transformed fibroblasts incubated with 10% plasma from two controls or from one patient (APS-I patient 7; means and errors bars from duplicates are shown). The data shown are representative of two experiments.

HHS Vulnerability Disclosure